Diversity in Clinical Trials: Tackling the Issues in Alzheimer’s Research at AAIC 2021
XTalks
JULY 29, 2021
times more likely than white Americans to suffer from dementia, less than one percent have participated in a National Institutes of Health (NIH) clinical trial. However, increasing diversity in Alzheimer’s trials is a multifactorial issue that requires understanding and solutions that address the many factors at play.
98 
Let's personalize your content